Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Cerebrovascular Disorders

  Free Subscription


Articles published in Circulation

Retrieve available abstracts of 78 articles:
HTML format
Text format



Single Articles


    May 2017
  1. DALE C, Fatemifar G, Palmer T, White J, et al
    Causal Associations of Adiposity and Body Fat Distribution with Coronary Heart Disease, Stroke Subtypes and Type 2 Diabetes: A Mendelian Randomization Analysis.
    Circulation. 2017 May 12. pii: CIRCULATIONAHA.116.026560.
    PubMed     Text format     Abstract available


  2. KUNZ A, Nolte CH, Erdur H, Fiebach JB, et al
    Effects of Ultraearly Intravenous Thrombolysis on Outcomes in Ischemic Stroke: The STEMO (Stroke Emergency Mobile) Group.
    Circulation. 2017;135:1765-1767.
    PubMed     Text format    


    April 2017
  3. ZHAO W, Meng R, Ma C, Hou B, et al
    Safety and Efficacy of Remote Ischemic Preconditioning in Patients With Severe Carotid Artery Stenosis Before Carotid Artery Stenting: A Proof-of-Concept, Randomized Controlled Trial.
    Circulation. 2017;135:1325-1335.
    PubMed     Text format     Abstract available


    March 2017
  4. HOPKINS LN, Holmes DR Jr
    Public Health Urgency Created by the Success of Mechanical Thrombectomy Studies in Stroke.
    Circulation. 2017;135:1188-1190.
    PubMed     Text format    


  5. BRIGHT CJ, Hawkins MM, Guha J, Henson KE, et al
    Risk of Cerebrovascular Events in 178 962 Five-Year Survivors of Cancer Diagnosed at 15 to 39 Years of Age: The TYACSS (Teenage and Young Adult Cancer Survivor Study).
    Circulation. 2017;135:1194-1210.
    PubMed     Text format     Abstract available


  6. WENDLER O, Schymik G, Treede H, Baumgartner H, et al
    SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.
    Circulation. 2017;135:1123-1132.
    PubMed     Text format     Abstract available


  7. SISCOVICK DS, Barringer TA, Fretts AM, Wu JH, et al
    Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.
    Circulation. 2017 Mar 13. pii: CIR.0000000000000482.
    PubMed     Text format     Abstract available



  8. Correction to: Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
    Circulation. 2017;135:e646.
    PubMed     Text format    


  9. LINDNER SM, Fordyce CB, Hellkamp AS, Lokhnygina Y, et al
    Treatment Consistency Across Levels of Baseline Renal Function With Rivaroxaban or Warfarin: A ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atria
    Circulation. 2017;135:1001-1003.
    PubMed     Text format    


    February 2017
  10. YOUNG LH, Viscoli CM, Curtis JP, Inzucchi SE, et al
    Cardiac Outcomes After Ischemic Stroke or TIA: Effects of Pioglitazone in Patients with Insulin Resistance Without Diabetes.
    Circulation. 2017 Feb 28. pii: CIRCULATIONAHA.116.024863.
    PubMed     Text format     Abstract available


  11. WHITMAN IR, Gladstone RA, Badhwar N, Hsia HH, et al
    Brain Emboli After Left Ventricular Endocardial Ablation.
    Circulation. 2017;135:867-877.
    PubMed     Text format     Abstract available



  12. Correction to: Restarting Anticoagulant Treatment After Intracranial Hemorrhage in Patients With Atrial Fibrillation and the Impact on Recurrent Stroke, Mortality, and Bleeding: A Nationwide Cohort Study.
    Circulation. 2017;135:e48.
    PubMed     Text format    


  13. QUINLAN DJ, Eikelboom JW, Hart RG
    Is There a Role for Betrixaban to Prevent Stroke in Medically Ill Patients?
    Circulation. 2017;135:656-658.
    PubMed     Text format    


  14. DUFOUIL C, Beiser AS, McClure LA, Wolf PA, et al
    A Revised Framingham Stroke Risk Profile to Reflect Temporal Trends.
    Circulation. 2017 Feb 3. pii: CIRCULATIONAHA.115.021275.
    PubMed     Text format     Abstract available


    January 2017
  15. BENJAMIN EJ, Blaha MJ, Chiuve SE, Cushman M, et al
    Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
    Circulation. 2017 Jan 25. pii: CIR.0000000000000485.
    PubMed     Text format    


  16. XIAN Y, Federspiel JJ, Hernandez AF, Laskowitz D, et al
    Use of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) Before Stroke.
    Circulation. 2017 Jan 24. pii: CIRCULATIONAHA.116.023940.
    PubMed     Text format     Abstract available


  17. OVBIAGELE B, Wang J, Johnston SC, Wang A, et al
    Effect of Clopidogrel by Smoking Status on Secondary Stroke Prevention.
    Circulation. 2017;135:315-316.
    PubMed     Text format    


  18. NIELSEN PB, Lip GY
    Adding Rigor to Stroke Rate Investigations in Patients With Atrial Fibrillation.
    Circulation. 2017;135:220-223.
    PubMed     Text format    


  19. ALBERTS MJ
    Stroke Treatment With Intravenous Tissue-Type Plasminogen Activator: More Proof That Time Is Brain.
    Circulation. 2017;135:140-142.
    PubMed     Text format    


  20. WANG W, Jiang B, Sun H, Ru X, et al
    Prevalence, Incidence and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480,687 Adults.
    Circulation. 2017 Jan 4. pii: CIRCULATIONAHA.116.025250.
    PubMed     Text format     Abstract available


  21. SIMON T, Danchin N
    Clinical Impact of Pharmacogenomics of Clopidogrel in Stroke.
    Circulation. 2017;135:34-37.
    PubMed     Text format    


    December 2016
  22. SCHWAMM LH, Chumbler N, Brown E, Fonarow GC, et al
    Recommendations for the Implementation of Telehealth in Cardiovascular and Stroke Care: A Policy Statement From the American Heart Association.
    Circulation. 2016 Dec 20. pii: CIR.0000000000000475.
    PubMed     Text format     Abstract available


  23. BIVARD A, Huang X, McElduff P, Levi CR, et al
    The Impact of CT Perfusion Imaging on the Response to Tenecteplase in Ischemic Stroke. Analysis of Two Randomized Controlled Trials.
    Circulation. 2016 Dec 13. pii: CIRCULATIONAHA.116.022582.
    PubMed     Text format     Abstract available


  24. HARTMANN D, Fiedler J, Sonnenschein K, Just A, et al
    MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease.
    Circulation. 2016;134:1973-1990.
    PubMed     Text format     Abstract available


  25. JOLLY SS, James SK, Dzavik V, Cairns JA, et al
    Thrombus Aspiration in ST Elevation Myocardial Infarction: An Individual Patient Meta-analysis.
    Circulation. 2016 Dec 9. pii: CIRCULATIONAHA.116.025371.
    PubMed     Text format     Abstract available


    November 2016
  26. MELDUNI RM, Schaff HV, Lee HC, Gersh BJ, et al
    Impact of Left Atrial Appendage Closure During Cardiac Surgery on the Occurrence of Early Postoperative Atrial Fibrillation, Stroke, and Mortality: A Propensity Score Matched Analysis of 10,633 Patients.
    Circulation. 2016 Nov 30. pii: CIRCULATIONAHA.116.021952.
    PubMed     Text format     Abstract available


  27. GAGGIN HK, Liu Y, Lyass A, van Kimmenade RR, et al
    Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
    Circulation. 2016 Nov 21. pii: CIRCULATIONAHA.116.023052.
    PubMed     Text format     Abstract available


  28. GIBSON CM, Chi G, Halaby R, Korjian S, et al
    Extended-Duration Betrixaban Reduces the Risk of Stroke Versus Standard-Dose Enoxaparin Among Hospitalized Medically Ill Patients: An APEX Trial Substudy (Acute Medically Ill Venous Thromboembolism Prevention With Extended Duration Betrixaban).
    Circulation. 2016 Nov 14. pii: CIRCULATIONAHA.116.025427.
    PubMed     Text format     Abstract available


  29. MENON BK, Hill MD, Goyal M
    Response by Menon et al to Letter Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e406-e407.
    PubMed     Text format    


  30. VENEMA E, Lingsma HF, Dippel DW
    Letter by Venema et al Regarding Article, "Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial".
    Circulation. 2016;134:e404-e405.
    PubMed     Text format    


  31. SHI L, Zhang D, Chen L, Truong KD, et al
    "Weekend Effect" or "Saturday Effect"? An Analysis of Hospital Mortality for Patients With Ischemic Stroke in South Carolina.
    Circulation. 2016;134:1510-1512.
    PubMed     Text format    


  32. WALSH KB, Woo D, Sekar P, Osborne J, et al
    Untreated Hypertension: A Powerful Risk Factor for Lobar and Nonlobar Intracerebral Hemorrhage in Whites, Blacks, and Hispanics.
    Circulation. 2016;134:1444-1452.
    PubMed     Text format     Abstract available


  33. ZUHLKE L, Karthikeyan G, Engel ME, Rangarajan S, et al
    Clinical Outcomes in 3343 Children and Adults With Rheumatic Heart Disease From 14 Low- and Middle-Income Countries: Two-Year Follow-Up of the Global Rheumatic Heart Disease Registry (the REMEDY Study).
    Circulation. 2016;134:1456-1466.
    PubMed     Text format     Abstract available


  34. KIM JT, Fonarow GC, Smith EE, Reeves MJ, et al
    Treatment with TPA in the "Golden Hour" and the Shape of the 4.5 Hour Time-Benefit Curve in the National US Get With The Guidelines-Stroke Population.
    Circulation. 2016 Nov 4. pii: CIRCULATIONAHA.116.023336.
    PubMed     Text format     Abstract available


  35. PAN Y, Chen W, Xu Y, Yi X, et al
    Genetic Polymorphisms and Clopidogrel Efficacy for Acute Ischemic Stroke or Transient Ischemic Attack: A Systematic Review and Meta-analysis.
    Circulation. 2016 Nov 2. pii: CIRCULATIONAHA.116.024913.
    PubMed     Text format     Abstract available


  36. HALPERIN JL, Savino JA 3rd
    Response by Halperin and Savino to Letter Regarding Article, "Should Patients with Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? The CHA2DS2-VASc 1 Conundrum: Decision Making at the Lower End
    Circulation. 2016;134:e391-e392.
    PubMed     Text format    


  37. NIELSEN PB, Lip GY
    Response by Nielsen and Lip to Letter Regarding Article, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke".
    Circulation. 2016;134:e389-e390.
    PubMed     Text format    


  38. ASINGER RW, Shroff GR, Herzog CA
    Letter by Asinger et al Regarding Articles, "Should Patients With Atrial Fibrillation and 1 Stroke Risk Factor (CHA2DS2-VASc Score 1 in Men, 2 in Women) Be Anticoagulated? Yes: Even 1 Stroke Risk Factor Confers a Real Risk of Stroke" and "Should Patie
    Circulation. 2016;134:e387-e388.
    PubMed     Text format    


    October 2016
  39. QUINN GR, Severdija ON, Chang Y, Singer DE, et al
    Wide Variation in Reported Rates of Stroke Across Cohorts of Patients with Atrial Fibrillation.
    Circulation. 2016 Oct 31. pii: CIRCULATIONAHA.116.024057.
    PubMed     Text format     Abstract available


  40. YANAGAWA B, Pettersson GB, Habib G, Ruel M, et al
    Surgical Management of Infective Endocarditis Complicated by Embolic Stroke: Practical Recommendations for Clinicians.
    Circulation. 2016;134:1280-1292.
    PubMed     Text format     Abstract available


  41. XIONG XY, Liu L, Wang FX, Yang YR, et al
    Toll-Like Receptor 4/MyD88-Mediated Signaling of Hepcidin Expression Causing Brain Iron Accumulation, Oxidative Injury, and Cognitive Impairment After Intracerebral Hemorrhage.
    Circulation. 2016;134:1025-1038.
    PubMed     Text format     Abstract available


    September 2016
  42. SEIDELMANN SB, Claggett B, Bravo PE, Gupta A, et al
    Retinal Vessel Calibers in Predicting Long-term Cardiovascular Outcomes: The Atherosclerosis Risk in Communities Study.
    Circulation. 2016 Sep 28. pii: CIRCULATIONAHA.116.023425.
    PubMed     Text format     Abstract available


  43. CHAO TF, Liu CJ, Liao JN, Wang KL, et al
    Response by Chao et al to Letters Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e230-1.
    PubMed     Text format    


  44. YANG X, An R, Xu Y
    Letter by Yang et al Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e228-9.
    PubMed     Text format    


  45. CHAN PH, Siu CW
    Letter by Chan and Siu Regarding Article, "Use of Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation Who Have a History of Intracranial Hemorrhage".
    Circulation. 2016;134:e226-7.
    PubMed     Text format    


    August 2016
  46. BONACA MP, Goto S, Bhatt DL, Steg PG, et al
    Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-T
    Circulation. 2016 Aug 30. pii: CIRCULATIONAHA.116.024637.
    PubMed     Text format     Abstract available


  47. OLDGREN J, Hijazi Z, Lindback J, Alexander JH, et al
    Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial Fibrillation.
    Circulation. 2016 Aug 28. pii: CIRCULATIONAHA.116.022802.
    PubMed     Text format     Abstract available


  48. BRAUN LT, Grady KL, Kutner JS, Adler E, et al
    Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association.
    Circulation. 2016 Aug 8. pii: CIR.0000000000000438.
    PubMed     Text format     Abstract available


  49. LIP GY
    Response by Lip to Letter Regarding Article, "How to Manage Occult Atrial Fibrillation Detected on Long-Term Monitoring".
    Circulation. 2016;134:e30-1.
    PubMed     Text format    


    July 2016
  50. PERALTA CA, McClure LA, Scherzer R, Odden MC, et al
    Response by Peralta et al to Letter Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Stroke
    Circulation. 2016;134:e26-7.
    PubMed     Text format    


  51. MEZUE K, Puri R, Rangaswami J
    Letter by Mezue et al Regarding Article, "Effect of Intensive Versus Usual Blood Pressure Control on Kidney Function Among Individuals With Prior Lacunar Stroke: A Post Hoc Analysis of the Secondary Prevention of Small Subcortical Strokes (SPS3) Rando
    Circulation. 2016;134:e24-5.
    PubMed     Text format    


  52. TANG SY, Monslow J, R Grant G, Todd L, et al
    Cardiovascular Consequences of Prostanoid I Receptor Deletion in Microsomal Prostaglandin E Synthase-1-Deficient Hyperlipidemic Mice.
    Circulation. 2016;134:328-38.
    PubMed     Text format     Abstract available


  53. HE VY, Condon JR, Ralph AP, Zhao Y, et al
    Long-Term Outcomes From Acute Rheumatic Fever and Rheumatic Heart Disease: A Data-Linkage and Survival Analysis Approach.
    Circulation. 2016;134:222-32.
    PubMed     Text format     Abstract available


  54. PICCINI JP, Hellkamp AS, Washam JB, Becker RC, et al
    Response by Piccini et al to Letters Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e7-8.
    PubMed     Text format    


  55. IMPRIALOS K, Boutari C, Stavropoulos K
    Letter by Imprialos et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e5-6.
    PubMed     Text format    


  56. BOUATOU Y, El Biali M, Samer CF
    Letter by Bouatou et al Regarding Article, "Polypharmacy and the Efficacy and Safety of Rivaroxaban Versus Warfarin in the Prevention of Stroke in Patients With Nonvalvular Atrial Fibrillation".
    Circulation. 2016;134:e3-4.
    PubMed     Text format    


  57. HERRMANN HC, Thourani VH, Kodali SK, Makkar RR, et al
    One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis.
    Circulation. 2016;134:130-40.
    PubMed     Text format     Abstract available


  58. HIJAZI Z, Wallentin L
    Renal Function in Atrial Fibrillation: A Multifaceted Dilemma.
    Circulation. 2016;134:48-51.
    PubMed     Text format    


  59. FORDYCE CB, Hellkamp AS, Lokhnygina Y, Lindner SM, et al
    On-Treatment Outcomes in Patients With Worsening Renal Function With Rivaroxaban Compared With Warfarin: Insights From ROCKET AF.
    Circulation. 2016;134:37-47.
    PubMed     Text format     Abstract available


    June 2016
  60. MENON BK, Sajobi TT, Zhang Y, Rempel JL, et al
    Analysis of Workflow and Time to Treatment on Thrombectomy Outcome in the Endovascular Treatment for Small Core and Proximal Occlusion Ischemic Stroke (ESCAPE) Randomized, Controlled Trial.
    Circulation. 2016;133:2279-86.
    PubMed     Text format     Abstract available


    May 2016
  61. SACCO RL, Roth GA, Reddy KS, Arnett DK, et al
    The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.
    Circulation. 2016 May 9. pii: CIR.0000000000000395.
    PubMed     Text format     Abstract available


  62. KEHREL BE, Fender AC
    Resolving Thromboinflammation in the Brain After Ischemic Stroke?
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.116.022858.
    PubMed     Text format     Abstract available


  63. VITAL SA, Becker F, Holloway PM, Russell J, et al
    Fpr2/ALX Regulates Neutrophil-Platelet Aggregation and Attenuates Cerebral Inflammation: Impact for Therapy in Cardiovascular Disease.
    Circulation. 2016 May 6. pii: CIRCULATIONAHA.115.020633.
    PubMed     Text format     Abstract available


  64. NAYOR M, Vasan RS
    Recent Update to the US Cholesterol Treatment Guidelines: A Comparison With International Guidelines.
    Circulation. 2016;133:1795-806.
    PubMed     Text format     Abstract available


    April 2016
  65. BLUMENTHAL JA, Sherwood A, Smith PJ, Watkins L, et al
    Enhancing Cardiac Rehabilitation With Stress Management Training: A Randomized, Clinical Efficacy Trial.
    Circulation. 2016;133:1341-50.
    PubMed     Text format     Abstract available


    March 2016
  66. KOVESDY CP, Norris KC, Boulware LE, Lu JL, et al
    Response to Letter Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".
    Circulation. 2016;133:e453.
    PubMed     Text format    


  67. KULLER LH, Neaton JD
    Letter by Kuller and Neaton Regarding Article, "Association of Race With Mortality and Cardiovascular Events in a Large Cohort of US Veterans".
    Circulation. 2016;133:e452.
    PubMed     Text format    


  68. BONACA MP, Gutierrez JA, Creager MA, Scirica BM, et al
    Acute Limb Ischemia and Outcomes With Vorapaxar in Patients With Peripheral Artery Disease: Results From the Trial to Assess the Effects of Vorapaxar in Preventing Heart Attack and Stroke in Patients With Atherosclerosis-Thrombolysis in Myocardial Inf
    Circulation. 2016;133:997-1005.
    PubMed     Text format     Abstract available


    February 2016
  69. ALFREDSSON J, Stebbins A, Brennan JM, Matsouaka R, et al
    Gait Speed Predicts 30-Day Mortality Following Transcatheter Aortic Valve Replacement: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Circulation. 2016 Feb 26. pii: CIRCULATIONAHA.115.020279.
    PubMed     Text format     Abstract available


  70. ECKEL RH, Hokanson JE
    The Prediction of Atherosclerotic Cardiovascular Disease in Type 1 Diabetes: Do We Just Stop Here?
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.116.021654.
    PubMed     Text format     Abstract available


  71. VISTISEN D, Andersen GS, Hansen CS, Hulman A, et al
    Prediction of First Cardiovascular Disease Event in Type 1 Diabetes: The Steno T1 Risk Engine.
    Circulation. 2016 Feb 17. pii: CIRCULATIONAHA.115.018844.
    PubMed     Text format     Abstract available


  72. SUMNER JA, Kubzansky LD, Elkind MS, Roberts AL, et al
    Response to Letter Regarding Article, "Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women".
    Circulation. 2016;133:e401-2.
    PubMed     Text format    


  73. DURMAZ O, Kucuk U, Olgun Kucuk H
    Letter by Durmaz et al Regarding Article, "Trauma Exposure and Posttraumatic Stress Disorder Symptoms Predict Onset of Cardiovascular Events in Women".
    Circulation. 2016;133:e400.
    PubMed     Text format    


  74. OPARIL S
    SPS3 Evidence Supports Intensive Blood Pressure Control.
    Circulation. 2016;133:552-4.
    PubMed     Text format    


  75. TONELLI M, Karumanchi SA, Thadhani R
    Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.
    Circulation. 2016;133:518-36.
    PubMed     Text format     Abstract available


    January 2016
  76. BARIK R
    Letter by Barik Regarding Article, "Now You See It, Now You Don't?".
    Circulation. 2016;133:e20.
    PubMed     Text format    


  77. POLLACK CV JR
    Cardiology Patient Pages: Antidotes for Bleeding Caused by Novel Oral Anticoagulants.
    Circulation. 2016;133:e18-9.
    PubMed     Text format    


  78. TRAN KA, Zhang X, Predescu D, Huang X, et al
    Endothelial beta-Catenin Signaling Is Required for Maintaining Adult Blood-Brain Barrier Integrity and Central Nervous System Homeostasis.
    Circulation. 2016;133:177-86.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cerebrovascular Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: